{
    "id": "professional_medicine-002",
    "question": "A 5-year-old boy is brought to the physician by his mother because of a 2-day history of a low-grade fever, cough, and runny nose. His temperature is 38\u00b0C (100.4\u00b0F). Examination findings are consistent with a diagnosis of a common cold. The physician refers to a randomized, double-blind, placebo-controlled clinical trial that evaluated the effectiveness of a new drug for the treatment of the common cold. The mean time for resolution of symptoms for patients receiving the new drug was 6.4 days, compared with a mean time of 6.7 days for patients receiving the placebo (p=0.04). Which of the following is the most appropriate interpretation of these study results?",
    "options": {
        "A": "The findings are clinically and statistically significant",
        "B": "The findings are clinically insignificant but statistically significant",
        "C": "The findings are clinically significant but statistically insignificant",
        "D": "The findings are neither clinically nor statistically significant"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine the most appropriate interpretation of the study results, we need to analyze the information provided. The study found that the mean time for resolution of symptoms for patients receiving the new drug was 6.4 days, compared to a mean time of 6.7 days for patients receiving the placebo (p=0.04). This indicates that the new drug was statistically significant in reducing the mean time for resolution of symptoms. However, we also need to consider the clinical significance of this finding. A 0.4-day difference in mean time for resolution of symptoms may not be clinically significant in the context of a common cold, which typically resolves on its own within 1 week. Therefore, we need to evaluate whether the difference in mean times is clinically significant in the context of the common cold. In general, a clinically significant difference is typically considered to be 1-2 days. In this case, the difference of 0.3 days (6.4 - 6.7) is within this range, suggesting that the finding may not be clinically significant. However, the study was a randomized, double-blind, placebo-controlled clinical trial, which suggests that the results are likely to be reliable. Therefore, the most appropriate interpretation of these study results is that the findings are statistically significant but not clinically significant.\", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "Pediatrics_Nelson_2246",
            "title": "Pediatrics_Nelson",
            "content": "There is no specific therapy for the common cold. Antibacterial therapy is not beneficial. Management consists of symptomatic therapies. Antihistamines, decongestants, and combination antihistamine-decongestants are not recommended for children younger than 6 years of age because of adverse effects and lack of benefits. Low-grade fever is seen with colds, particularly in the first few days of illness and can be treated with antipyretic medications. Cough suppressants and expectorants have not been shown to be beneficial. Vitamin C and inhalation of warm, humidified air are no more effective than placebo. The benefit of zinc lozenges or sprays has been inconsistent."
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "InternalMed_Harrison_14728",
            "title": "InternalMed_Harrison",
            "content": "Influenza is most frequently described as a respiratory illness characterized by systemic symptoms, such as headache, feverishness, chills, myalgia, and malaise, as well as accompanying respiratory tract signs and symptoms, particularly cough and sore throat. In some cases, the onset is so abrupt that patients can recall the precise time they became ill. However, the spectrum of clinical presentations is wide, ranging from a mild, afebrile respiratory illness similar to the common cold (with either a gradual or an abrupt onset) to severe prostration with relatively few respiratory signs and symptoms. In most of the cases that come to a physician\u2019s attention, the patient has a fever, with temperatures of 38\u00b0\u201341\u00b0C (100.4\u00b0\u2013105.8\u00b0F). A rapid temperature rise within the first 24 h of illness is generally followed by gradual defervescence over 2\u20133 days, although, on occasion, fever may last as long as 1 week."
        },
        {
            "id": "Pharmacology_Katzung_7020",
            "title": "Pharmacology_Katzung",
            "content": "of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her current medications include Norco 5/325 (hydrocodone 5 mg/ acetaminophen 325 mg per tablet; two tablets four times daily for pain) and loratadine (10 mg daily). The patient also reported recent use of several over-the-counter (OTC) medications over the past 3 days to treat the new-onset flu symptoms, including Alka-Seltzer Plus Severe Cold + Flu (two tablets every 4 hours during the day) and Tylenol PM (two tablets at bedtime)."
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "Pediatrics_Nelson_2244",
            "title": "Pediatrics_Nelson",
            "content": "Available @ StudentConsult.com Common cold symptoms typically develop 1 to 3 days after viral infection and include nasal obstruction, rhinorrhea, sore or scratchy throat, and occasional nonproductive cough. Colds usually persist about 1 week, although 10% last 2 weeks. There is often a change in the color or consistency of nasal secretions, which is not indicative of sinusitis or bacterial superinfection. Examination of the nasal mucosa may reveal swollen, erythematous nasal turbinates. Laboratory studies often are not helpful. A nasal smear for eosinophils may be useful in the evaluation for allergic rhinitis (see Chapter 79)."
        },
        {
            "id": "InternalMed_Harrison_10656",
            "title": "InternalMed_Harrison",
            "content": "that vancomycin, fidaxomicin, and metronidazole be given for at least 10 days. Metronidazole is not approved for CDI by the U.S. Food and Drug Administration (FDA), but most patients with mild to moderate illness respond to 500 mg given by mouth three times a day for 10 days; extension of the treatment period may be needed for slow responders. In addition to the reports of increases in metronidazole failures, a prospective, randomized, double-blind, placebo-controlled study has demonstrated the superiority of vancomycin over metronidazole for treatment of severe CDI. The severity assessment score in that study included age as well as laboratory parameters (elevated temperature, low albumin level, or elevated WBC count), documentation of PMC by endoscopy, and treatment of CDI in the intensive care unit. Although a validated severity score is not available, it is important to initiate treatment with oral vancomycin for patients who appear seriously ill, particularly if they have a high"
        },
        {
            "id": "Pediatrics_Nelson_2247",
            "title": "Pediatrics_Nelson",
            "content": "Otitis media is the most common complication and occursin 5% to 20% of children with a cold (see Chapter 105). Othercomplications include bacterial sinusitis, which should beconsidered if rhinorrhea or daytime cough persists without improvement for at least 10 to 14 days or if severe signsof sinus involvement develop, such as fever, facial pain, orfacial swelling (see Chapter 104). Colds may lead to exacerbation of asthma and may result in inappropriate antibiotic treatment. There are no proven methods for prevention of colds other than good hand washing and avoiding contact with infected persons. No significant effect of vitamin C or Echinacea for prevention of the common cold has been confirmed."
        },
        {
            "id": "Pharmacology_Katzung_5286",
            "title": "Pharmacology_Katzung",
            "content": "Harry W. Lampiris, MD, & Daniel S. Maddix, Pharm D The patient is a 37-year-old African-American man who lives in San Jose, California. He was recently incarcerated near Bakersfield, California and returned to Oakland about 3 months ago. He is currently experiencing one month of severe headache and double vision. He has a temperature of 38.6\u00b0C (101.5\u00b0F) and the physical exam reveals nuchal rigidity and right-sided sixth cranial nerve palsy. MRI of his brain is normal, and lumbar puncture reveals 330 WBC with 20% eosinophils, protein 75, and glucose 20. HIV test is negative, TB skin test is negative, CSF cryptococcal antigen is negative, and CSF gram stain is negative. Patient receives empiric therapy for bacterial meningitis with van-comycin and ceftriaxone, and is unimproved after 72 hours of treatment. After 3 days a white mold is identified growing from his CSF culture. What medical therapy would be most appropriate now?"
        },
        {
            "id": "Pharmacology_Katzung_7081",
            "title": "Pharmacology_Katzung",
            "content": "Echinacea is most often used to enhance immune function in individuals who have colds and other respiratory tract infections. Two reviews have assessed the efficacy of echinacea for this primary indication. A review by the Cochrane Collaboration involved 24 randomized, double-blind trials with 33 comparisons of echinacea mono-preparations, which are single-ingredient echinacea preparations, and placebo. Trials were included if they involved echinacea for cold treatment or prevention, where the primary efficacy outcome was cold incidence in prevention trials and duration of symptoms in treatment trials. Overall, the review did not find significant evidence of benefit for echinacea (among all species) in treating colds. Preparations made from the aerial parts of E purpurea plants and prepared as alcoholic extracts or pressed juices were discussed as possibly being preferred to other formulations for cold treatment in adults, but still having a weak overall treatment effect. In"
        },
        {
            "id": "InternalMed_Harrison_2567",
            "title": "InternalMed_Harrison",
            "content": "differences in host response as well as in infecting organisms; myalgias and fatigue, for example, sometimes are seen with influenza and parainfluenza infections, whereas conjunctivitis may suggest infection with adenovirus or enterovirus. Findings on physical examination are frequently nonspecific and unimpressive. Between 0.5% and 2% of colds are complicated by secondary bacterial infections (e.g., rhinosinusitis, otitis media, and pneumonia), particularly in higher-risk populations such as infants, elderly persons, and chronically ill or immunosuppressed individuals. Secondary bacterial infections usually are associated with a prolonged course of illness, increased severity of illness, and localization of signs and symptoms, often as a rebound after initial clinical improvement (the \u201cdouble-dip\u201d sign). Purulent secretions from the nares or throat often are misinterpreted as an indication of bacterial sinusitis or pharyngitis. These secretions, however, can be seen in nonspecific"
        },
        {
            "id": "InternalMed_Harrison_14016",
            "title": "InternalMed_Harrison",
            "content": "Although in the majority of untreated cases symptoms resolve within 2\u20133 weeks without significant associated morbidity, M. pneumoniae pneumonia can be a serious illness that responds to appropriate antimicrobial therapy (Table 212-2). Randomized, double-blind, placebo-controlled trials in adults have demonstrated that antimicrobial treatment significantly decreases the duration of fever, cough, malaise, hospitalization, and radiologic abnormalities in M. pneumoniae pneumonia. Treatment options for acute M. pneumoniae infection include macrolides (e.g., oral azithromycin, 500 mg on day 1, then 250 mg/d on days 2\u20135), tetracyclines (e.g., oral doxycycline, 100 mg twice daily for 10\u201314 days), and respiratory fluoroquinolones. However, ciprofloxacin and ofloxacin are not recommended because of their high minimal inhibitory concentrations against M. pneumoniae isolates and their poor performance in experimental studies. A 10to 14-day course of quinolone therapy appears adequate."
        },
        {
            "id": "Pharmacology_Katzung_7114",
            "title": "Pharmacology_Katzung",
            "content": "were evaluated. Nine of the studies reported significant reductions in blood glucose. Some randomized, placebo-controlled trials have reported immunomodulating benefits of P quinquefolium and P ginseng in preventing upper respiratory tract infections. Use of ginseng for 2\u20134 months in healthy seniors may reduce the risk of acquiring the common cold as well as the duration of symptoms. Because of heterogeneity in these trials, however, the findings are insufficient to warrant a recommendation of ginseng for cold prevention. To assess effects on cardiovascular health, a systematic review and meta-analysis of 17 randomized controlled trials involving predominantly P ginseng (12 studies) and P quinquefolium (5 studies) species in persons with and without hypertension was performed. Over a mean time period of 9 weeks, no significant effect was observed of ginseng on SBP, DBP, and mean arterial pressure compared with controls. Finally, two case-control studies and a cohort study suggest a"
        },
        {
            "id": "InternalMed_Harrison_2585",
            "title": "InternalMed_Harrison",
            "content": "Most patients with a clinical diagnosis of acute rhinosinusitis improve without antibiotic therapy. The preferred initial approach in patients with mild to moderate symptoms of short duration is therapy aimed at symptom relief and facilitation of sinus drainage, such as with oral and topical decongestants, nasal saline lavage, and\u2014at least in patients with a history of chronic sinusitis or allergies\u2014nasal glucocorticoids. Newer studies have cast doubt on the role of antibiotics and nasal glucocorticoids in acute rhinosinusitis. In one notable double-blind, randomized, placebo-controlled trial, neither antibiotics nor topical glucocorticoids had a significant impact on cure in the study population of patients, the majority of whom had had symptoms for <7 days. Similarly, another high-profile randomized trial comparing antibiotics to placebo in patients with acute rhinosinusitis demonstrated no significant improvement in symptoms by the third day of therapy. Still, antibiotic therapy"
        },
        {
            "id": "InternalMed_Harrison_32372",
            "title": "InternalMed_Harrison",
            "content": "drug of choice for AMS prevention. It inhibits renal carbonic anhydrase, causing a prompt bicarbonate diuresis that leads to metabolic acidosis and hyperventilation. Acetazolamide (125\u2013250 mg twice a day), administered for 1 day before ascent and continued for 2 or 3 days, is effective. Higher doses are not required. A meta-analysis limited to randomized controlled trials revealed that 125 mg of acetazolamide twice daily was effective in the prevention of AMS, with a relative-risk reduction of ~48% from values obtained with placebo. Paresthesia and a tingling sensation are common side effects of acetazolamide. This drug is a nonantibiotic sulfonamide that has low-level cross-reactivity with sulfa antibiotics; as a result, severe reactions are rare. Dexamethasone (8 mg/d in divided doses) is also effective. A large-scale, randomized, double-blind, placebo-controlled trial in partially acclimated trekkers has clearly shown that Ginkgo biloba is ineffective in the prevention of AMS."
        },
        {
            "id": "Pharmacology_Katzung_5118",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man with no significant medical history was admitted to the intensive care unit (ICU) 10 days ago after suffering third-degree burns over 40% of his body. He had been relatively stable until the last 24 hours. Now, he is febrile (39.5\u00b0C [103.1\u00b0F]), and his white blood cell count has risen from 8500 to 20,000/mm3. He has also had an episode of hypo-tension (86/50 mmHg) that responded to a fluid bolus. Blood cultures were obtained at the time of his fever and results are pending. The ICU attending physician is concerned about a bloodstream infection and decides to treat with empiric com-bination therapy directed against Pseudomonas aeruginosa. The combination therapy includes tobramycin. The patient weighs 70 kg (154 lb) and has an estimated creatinine clear-ance of 90 mL/min. How should tobramycin be dosed using once-daily and conventional dosing strategies? How should each regimen be monitored for efficacy and toxicity?"
        },
        {
            "id": "Pharmacology_Katzung_7115",
            "title": "Pharmacology_Katzung",
            "content": "time period of 9 weeks, no significant effect was observed of ginseng on SBP, DBP, and mean arterial pressure compared with controls. Finally, two case-control studies and a cohort study suggest a non-organ-specific cancer-preventive effect with longterm administration of P ginseng. Significant benefits in some cancer-related fatigue symptoms have been observed in both a dose-finding study and a multisite, double-blind, randomized trial using P quinquefolium, 2 g daily, versus placebo over a 2-month period. In summary, the strongest support for use of P ginseng or P quinquefolium currently relates to its effects in cold prevention, lowering postprandial glucose, nonspecific cancer prevention, and alleviating cancer-related fatigue."
        },
        {
            "id": "Pharmacology_Katzung_5171",
            "title": "Pharmacology_Katzung",
            "content": "A 59-year-old woman presents to an urgent care clinic with a 4-day history of frequent and painful urination. She has had fevers, chills, and flank pain for the past 2 days. Her physician advised her to come immediately to the clinic for evaluation. In the clinic she is febrile (38.5\u00b0C [101.3\u00b0F]) but otherwise stable and states she is not experiencing any nausea or vomiting. Her urine dipstick test is positive for leukocyte esterase. Urinalysis and urine culture are ordered. Her past medical history is significant for three urinary tract infections in the past year. Each episode was uncom-plicated, treated with trimethoprim-sulfamethoxazole, and promptly resolved. She also has osteoporosis for which she takes a daily calcium supplement. The decision is made to treat her with oral antibiotics for a complicated urinary tract infection with close follow-up. Given her history, what would be a reasonable empiric antibiotic choice? Depending on the antibiotic choice are there potential drug"
        },
        {
            "id": "Pharmacology_Katzung_4939",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man is brought to the local hospital emer-gency department by ambulance. His wife reports that he had been in his normal state of health until 3 days ago when he developed a fever and a productive cough. Dur-ing the last 24 hours he has complained of a headache and is increasingly confused. His wife reports that his medical history is significant only for hypertension, for which he takes hydrochlorothiazide and lisinopril, and that he is allergic to amoxicillin. She says that he developed a rash many years ago when prescribed amoxicillin for bron-chitis. In the emergency department, the man is febrile (38.7\u00b0C [101.7\u00b0F]), hypotensive (90/54 mmHg), tachypneic (36/min), and tachycardic (110/min). He has no signs of meningismus but is oriented only to person. A stat chest x-ray shows a left lower lung consolidation consistent with pneumonia. A CT scan is not concerning for lesions or elevated intracranial pressure. The plan is to start empiric antibiotics and perform a"
        },
        {
            "id": "Pediatrics_Nelson_1820",
            "title": "Pediatrics_Nelson",
            "content": "with colds. Chronic infectious rhinosinusitis, or sinusitis, should be suspected if there is mucopurulent nasal discharge with symptoms that persist beyond 10 days (see Chapter 104). Classic signs of acute sinusitis in older children include facial tenderness, tooth pain, headache, and fever. Classic signs are usually not present in young children who may present with postnasal drainage with cough, throat clearing, halitosis, and rhinorrhea. The character of the nasal secretions with infectious rhinitis varies from purulent to minimal or absent. Coexistence of middle ear disease, such as otitis media or eustachian tube dysfunction, may be additional clues of infection."
        },
        {
            "id": "Pharmacology_Katzung_5216",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD* A 60-year-old man presents to the emergency department with a 2-month history of fatigue, weight loss (10 kg), fevers, night sweats, and a productive cough. He is currently living with friends and has been intermittently homeless, spending time in shelters. He reports drinking about 6 beers per day. In the emergency department, a chest x-ray shows a right apical infiltrate. Given the high suspicion for pulmonary tuberculosis, the patient is placed in respiratory isolation. His first sputum smear shows many acid-fast bacilli, and an HIV test returns with a positive result. What drugs should be started for treatment of presumptive pulmonary tubercu-losis? Does the patient have a heightened risk of developing medication toxicity? If so, which medication(s) would be likely to cause toxicity?"
        },
        {
            "id": "InternalMed_Harrison_14729",
            "title": "InternalMed_Harrison",
            "content": "1212 Patients report a feverish feeling and chilliness, but true rigors are rare. Headache, either generalized or frontal, is often particularly troublesome. Myalgias may involve any part of the body but are most common in the legs and lumbosacral area. Arthralgias may also develop. Respiratory symptoms often become more prominent as systemic symptoms subside. Many patients have a sore throat or persistent cough, which may last for \u22651 week and which is often accompanied by substernal discomfort. Ocular signs and symptoms include pain on motion of the eyes, photophobia, and burning of the eyes. In the elderly, influenza may have a relatively subtle presentation. Typical features such as sore throat, myalgia, and even fever may be absent, and general symptoms such as anorexia, malaise, weakness, and dizziness may predominate. Physical findings are usually minimal in uncomplicated influenza. Early in the illness, the patient appears flushed, and the skin is hot and dry, although"
        },
        {
            "id": "Pediatrics_Nelson_1937",
            "title": "Pediatrics_Nelson",
            "content": "The acute phase of KD, which lasts 1 to 2 weeks, is marked by sudden onset of a high, hectic fever (>40 \u00b0C) without an apparent source. The onset of fever is followed by conjunctival erythema; mucosal changes, including dry, cracked lips and a strawberry tongue; cervical lymphadenopathy; and swelling of the hands and feet (Fig. 88-1). Conjunctivitis is bilateral, bulbar, and nonsuppurative. Cervical lymphadenopathy is found in 70% of children and should be greater than 1.5 cm in diameter for the purposes of diagnosis. A rash, which can vary in appearance, occurs in 80% of children with KD and may be particularly accentuated in the inguinal area and on the chest. Extreme irritability is prominent, especially in infants. Abdominal pain and hydrops of the gallbladder, cerebrospinal fluid pleocytosis, sterile pyuria, and arthritis, particularly of medium-sized to large joints, may occur. Carditis in the acute phase may be manifested by tachycardia, shortness of breath, or overt congestive"
        },
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "InternalMed_Harrison_32394",
            "title": "InternalMed_Harrison",
            "content": "High-Altitude Cough High-altitude cough can be debilitating and is sometimes severe enough to cause rib fracture, especially at >5000 m. The etiology is probably multifactorial. Although high-altitude cough has been attributed to inspiration of cold dry air, this explanation appears not to be sufficient by itself; in long-duration studies in hypobaric chambers, cough has occurred despite controlled temperature and humidity. The implication is that hypoxia also plays a role. Exercise can precipitate cough at high altitudes, possibly because of water loss from the respiratory tract. Long-acting \u03b2 agonists and glucocorticoids prevent bronchoconstriction that otherwise may be brought on by cold and exercise. In general, infection does not seem to be a common etiology. Anecdotal reports have described the efficacy of an inhaled combination of fluticasone and salmeterol in the treatment of high-altitude cough; however, a placebo-controlled, randomized trial failed to support this beneficial"
        },
        {
            "id": "Pharmacology_Katzung_7083",
            "title": "Pharmacology_Katzung",
            "content": "A separate meta-analysis involving 14 randomized, placebo-controlled trials of echinacea for cold treatment or prevention was published in Lancet. In this review, echinacea decreased the risk of developing clear signs and symptoms of a cold by 58% and decreased symptom duration by 1.25 days. This review, however, was confounded by the inclusion of four clinical trials involving multi-ingredient echinacea preparations, as well as three studies using rhinovirus inoculation versus natural cold development. Echinacea has been used investigationally to enhance hematologic recovery following chemotherapy. It has also been used as an adjunct in the treatment of urinary tract and vaginal fungal infections. These indications require further research before they can be accepted in clinical practice. E purpurea is ineffective in treating recurrent genital herpes."
        },
        {
            "id": "Biochemistry_Lippincott_1917",
            "title": "Biochemistry_Lippinco",
            "content": "Q2. Which of the following statements concerning the actions of epinephrine and/or NE are correct? A. NE functions as a neurotransmitter and a hormone. B. They are initiated by autophosphorylation of select tyrosine residues in their receptors. C. They are mediated by binding to adrenergic receptors, which are a class of nuclear receptors. D. They result in the activation of glycogen and triacylglycerol synthesis. Q3. NE bound to certain receptors causes vasoconstriction and an increase in blood pressure. Why might NE be used clinically in the treatment of septic shock? Case 5: Sun Sensitivity Patient Presentation: AZ is a 6-year-old boy who is being evaluated for freckle-like areas of hyperpigmentation on his face, neck, forearms, and lower legs. Focused History: AZ\u2019s father reports that the boy has always been quite sensitive to the sun. His skin turns red (erythema) and his eyes hurt (photophobia) if he is exposed to the sun for any period of time."
        },
        {
            "id": "Pharmacology_Katzung_7086",
            "title": "Pharmacology_Katzung",
            "content": "It is recommended to follow the dosing on the package label, as there may be variations in dose based on the procedure used in product manufacture. Standardized preparations made from the aerial parts of E purpurea (Echinaforce, Echinaguard) as an alcoholic extract or fresh pressed juice may be preferred in adults for common cold treatment if taken within the first 24 hours of cold symptoms. It should not be used on a continuous basis for longer than 10\u201314 days."
        },
        {
            "id": "InternalMed_Harrison_27720",
            "title": "InternalMed_Harrison",
            "content": "Lorcaserin has undergone two randomized, placebo-controlled, double-blind trials for efficacy and safety. Participants were randomized to receive lorcaserin (10 mg bid) or placebo in the BLOOM study and to receive lorcaserin (10 mg bid or qd) or placebo in the BLOSSOM study. All participants received diet and exercise counseling. Participant numbers, eligibility, characteristics, and weight loss outcomes are displayed in Table 416-6. Overweight or obese subjects had at least one coexisting condition (hypertension, dyslipidemia, cardiovascular disease, impaired glucose tolerance, or sleep apnea)\u2014medical conditions that are commonly seen in the office setting. Intention-to-treat 1-year placebo-subtracted weight loss was 3.6% and 3.0%, respectively, in the BLOOM and BLOSSOM trials. Echocardiography was performed at the screening visit and at scheduled time points over the course of the studies. There was no difference in the development of FDA-defined valvulopathy between drug-treated"
        },
        {
            "id": "Pediatrics_Nelson_2242",
            "title": "Pediatrics_Nelson",
            "content": "The common cold is a viral infection with prominent symptoms of rhinorrhea and nasal obstruction, absent or mild fever, and no systemic manifestations. It is often referred to as rhinitis but usually involves the sinus mucosa and is more correctly termed rhinosinusitis. The viruses primarily associated with colds are rhinoviruses and, less commonly, coronaviruses. Other viruses that cause common cold symptoms include respiratory syncytial virus and, less commonly, influenza, parainfluenza, and adenoviruses. Viral infection of nasal epithelium causes an acute inflammatory response with mucosal infiltration by inflammatory cells and release of cytokines. The inflammatory response is partly responsible for many of the symptoms."
        },
        {
            "id": "Biochemistry_Lippincott_1920",
            "title": "Biochemistry_Lippinco",
            "content": "B. in eukaryotes requires condensation of chromatin. C. in prokaryotes is accomplished by a single DNA polymerase. D. is initiated at random sites in the genome. E. produces a polymer of deoxyribonucleoside monophosphates linked by 5\u2032\u21923\u2032-phosphodiester bonds. . What is the difference between DNA proofreading and repair? Case 6: Dark Urine and Yellow Sclerae Patient Presentation: JF is a 13-year-old boy who presents with fatigue and yellow sclerae. Focused History: JF began treatment ~4 days ago with a sulfonamide antibiotic and a urinary analgesic for a urinary tract infection. He had been told that his urine would change color (become reddish) with the analgesic, but he reports that it has gotten darker (more brownish) over the last 2 days. Last night, his mother noticed that his eyes had a yellow tint. JF says he feels as though he has no energy."
        },
        {
            "id": "First_Aid_Step2_1260",
            "title": "First_Aid_Step2",
            "content": "Life-threatening muscle rigidity, fever, and rhabdomyolysis. Amenorrhea, bradycardia, and abnormal body image in a young female. SSRIs. MAOIs. Patient on dopamine antagonist. Conversion disorder. Neuroleptic malignant syndrome. Anorexia. A 35-year-old man has recurrent episodes of palpitations, diaphoresis, and fear of going crazy. The most serious side effect of clozapine. A 21-year-old man has three months of social withdrawal, worsening grades, \ufb02attened affect, and concrete thinking. Key side effects of atypical antipsychotics. A young weight lifter receives IV haloperidol and complains that his eyes are deviated sideways. Diagnosis? Treatment? Medication to avoid in patients with a history of alcohol withdrawal seizures. A 13-year-old boy has a history of theft, vandalism, and violence toward family pets. A five-month-old girl has \u2193 head growth, truncal dyscoordination, and \u2193 social interaction."
        }
    ],
    "scores": [
        0.037366141446981506,
        0.03386007019188059,
        0.02751637471439452,
        0.026321992268836122,
        0.02458802278433355,
        0.024385615772666267,
        0.023013777003138704,
        0.022394795127353265,
        0.02175216610681566,
        0.021696369745986828,
        0.01890999910801891,
        0.01889483065953654,
        0.018207282913165264,
        0.017679127725856697,
        0.016101207590569294,
        0.01605392156862745,
        0.01601731601731602,
        0.01575757575757576,
        0.015696649029982364,
        0.01552757793764988,
        0.015193747608897632,
        0.014906832298136646,
        0.01490015360983103,
        0.014796026210103572,
        0.014775668679896463,
        0.014578032230703985,
        0.014434643143544507,
        0.014029923963698798,
        0.013912469345406527,
        0.013910060975609756,
        0.013419216317767043,
        0.013204187117230596
    ],
    "execution_time": 57.19953274726868
}